Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy

BACKGROUND: Uremic cardiomyopathy contributes substantially to mortality in chronic kidney disease (CKD) patients. Glucagon-like peptide-1 (GLP-1) may improve cardiac function, but is mainly degraded by dipeptidyl peptidase-4 (DPP-4). METHODOLOGY/PRINCIPAL FINDINGS: In a rat model of chronic renal f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaykovska, Lyubov, von Websky, Karoline, Rahnenführer, Jan, Alter, Markus, Heiden, Susi, Fuchs, Holger, Runge, Frank, Klein, Thomas, Hocher, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220703/
https://www.ncbi.nlm.nih.gov/pubmed/22125632
http://dx.doi.org/10.1371/journal.pone.0027861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220703/
https://www.ncbi.nlm.nih.gov/pubmed/22125632
http://dx.doi.org/10.1371/journal.pone.0027861

Ejemplares similares